BioSpace News Archive

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for year ended December 31, 2022, on Thursday, March 30, 2023, after the close of the U.S. financial markets.

Hyperfine, Inc. announced fourth quarter and full year 2022 financial results and provided a business update.

TELA Bio, Inc. (“TELA Bio”) today reported financial results for the fourth quarter and full year ended December 31, 2022.

PepGen Inc. (Nasdaq: PEPG) today announced that James McArthur, Ph.D., President and CEO of PepGen will present at Stifel’s CNS Days Conference on Tuesday, March 28th at 1:30pm EST.

Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS) today announced that the Company will host a conference call and webcast on March 28, 2023 at 4:30 pm ET (1:30 pm PT) to provide a business update and report fourth quarter and full year 2022 financial results.

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and reported financial results for the fourth quarter and full-year ended December 31, 2022.

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced its financial results for the fourth quarter and full year ended December 31, 2022, and recent corporate developments.

Jiangsu Recbio Technology Co., Ltd. is pleased to announce that in accordance with the Mongolian law on the prevention of novel coronavirus outbreak, the Company was granted an Emergency Use Authorization for its two-component recombinant COVID-19 vaccine ReCOV by Order No. A106 of the Minister of Public Health of Mongolia and a resolution of the Mongolian Committee for Medicinal Products for Human Use.

Scorpius BioManufacturing, a Texas-based biologics contract research and contract development & manufacturing organization, announced the appointment of Gary Welch as Interim President.

Mainz Biomed NV announced that Bill Caragol, the Company’s CFO, will present and host one-on-one meetings with investors at the Sidoti March Virtual Investor Conference, taking place on March 22-23, 2023.